High Court overturns tribunal decision on ayurvedic medicines, emphasizes valid drug license & medicinal value

The High Court ruled in favor of the appellant, setting aside the tribunal's order and the Excise & Taxation Commissioner's decision. The judgment emphasized the importance of a valid drug license and the presence of medicinal value in the ingredients to classify products as ayurvedic medicines and qualify for a lower tax rate as per the relevant legal provisions and precedents.

---

---

Issues:
1. Interpretation of tax liability on specific items under the Punjab Value Added Tax Act, 2005.
2. Classification of goods 'Choloromint Herbasol' and 'Happydent White' as medicines.
3. Applicability of tax rate on ayurvedic medicines under Schedule B of PVAT Act, 2005.

Issue 1: Interpretation of tax liability under PVAT Act, 2005
The appellant challenged an order by the Value Added Tax Tribunal regarding the tax rate applicability on items manufactured by them. The dispute revolved around the items 'Choloromint Herbasol', 'Happydent White', and 'Chatar Patar' being taxed at 12.5% under Schedule 'F' of PVAT Act, 2005. The appellant contended that the High Court judgments from Uttrakhand and Allahabad supported their claim for a lower tax rate.

Issue 2: Classification of goods as medicines
The appellant argued that the items 'Choloromint Herbasol' and 'Happydent White' should be classified as medicines based on judgments from Uttrakhand, Allahabad, and Telangana High Courts. These judgments highlighted that the products were manufactured under a valid drug license and contained organic ingredients with medicinal value, thus qualifying as ayurvedic medicines.

Issue 3: Applicability of tax rate on ayurvedic medicines
The High Court analyzed the provisions of the Punjab Value Added Tax Act, 2005, and the Drugs and Cosmetics Act to determine the tax liability on ayurvedic medicines. The court referred to Entry 31 of Schedule B, which covers drugs and medicines produced under a drug license, supporting the appellant's claim for a 4% tax rate based on the consistent legal interpretations from various High Courts and the Supreme Court.

In conclusion, the High Court ruled in favor of the appellant, setting aside the tribunal's order and the Excise & Taxation Commissioner's decision. The judgment emphasized the importance of a valid drug license and the presence of medicinal value in the ingredients to classify products as ayurvedic medicines and qualify for a lower tax rate as per the relevant legal provisions and precedents.

---